Post hoc analysis of the GATHER1 and GATHER2 pivotal studies has shown that treatment with Izervay (Astellas) reduced the risk of progressing to loss of driving eligibility compared with sham over 24 months in patients with geographic atrophy (GA) secondary to age-related macular degeneration (AMD). The findings, presented at the Association for Research in Vision and Ophthalmology (ARVO) annual meeting in

When Optometry Australia’s members voted earlier this year to dissolve five separate state-based divisions and merge into a single national entity, the result was decisive across every jurisdiction. Now the structural transition is moving at pace.

New research suggests that measuring biological ageing could enable clinicians to identify patients at elevated risk of cataracts before significant vision loss occurs, potentially opening the door to earlier preventive strategies.1

An international team has created the most detailed picture yet of how genetic differences shape the way the human eye works, uncovering how both common and rare DNA variants influence gene activity in the eye and potentially contribute to blinding diseases.

A prospective controlled study published in Frontiers in Ophthalmology has found that Optimel Manuka+ Dry Eye Drops may offer meaningful symptomatic relief for patients experiencing dry eye disease following cataract surgery.1

A completely new drug candidate – called a small molecule ‘photoswitch’ – has moved into a Phase 2 trial after a successful first-in-human trial in Adelaide that saw one blind retinitis pigmentosa (RP) patient regain light perception for the first time in 10 years.

A single low-dose atropine eye drop (0.01%–0.1%) can produce daylong effects in managing myopia, without short-term structural effects on the eye, according to new research from University of Houston.1

The Australian Health Practitioner Regulation Agency (Ahpra) and the National Boards have committed to strengthen the health workforce’s ability to recognise and respond to family domestic and sexual violence (FDSV).

A new National Model for Clinical Governance1 has been developed to support public and private hospitals to deliver better outcomes for patients. The model has been designed for all types of acute healthcare delivery, including face-to-face and virtual care, amid mounting pressures on the health system.

A new study has found gum disease is associated with a higher risk of developing several ocular diseases.1

A narrative review has found lower serum vitamin D levels are frequently associated with higher myopia prevalence and longer axial length in paediatric, adolescent, and young adult patients.1

Researchers in South Korea have developed experimental smart contact lenses that use gentle electrical stimulation to reduce depression-like symptoms in mice, opening a possible new frontier in non-invasive brain therapy.

Registrations are open for Optometry Australia’s Optometry Clinical Conference (OCC) 2026 at the Brisbane Convention and Exhibition Centre from 9–10 August 2026.

The Australian Health Practitioner Regulation Agency (Ahpra) is seeking feedback on proposed changes to recency of practice (ROP) and continuing professional development (CPD) registration standards.

A new app is now available for optometrists and ophthalmologists who regularly perform Esterman testing. Estermate, developed by ophthalmologist Dr Jeremy Tan, a clinician-researcher with interests in visual fields and glaucoma, offers a practical way to work through driving eligibility criteria systematically, particularly when the defect pattern is complex or the applicability of a concession is uncertain.

Bausch and Lomb has launched PreserVision AREDS3 eye vitamins in the United States.

Jayden Jap, a fourth-year optometry student at Queensland University of Technology (QUT), has been recognised with the mivision award for communication at the QUT student awards for the 2025 academic year.

A new patient-specific app has been released to inform patients about their cataract surgery procedure, what is involved in the process, the primary risks that may be encountered, how these may be mitigated, and the patient’s expected pathway to recovery.

Sydney ophthalmologist Dr Simon Chen explains how a borderline case, a quiet correction from an optometrist, and a failed image-parsing artificial intelligence (AI) experiment led to a free Austroads driving-fields tool for Australian clinicians.

The management approach to diabetic retinopathy and diabetic macular oedema has evolved substantially in recent years, necessitating updates to clinical practice. This shift has been driven by two major factors: The rapidly increasing global prevalence of diabetes and the availability of newer, more effective ophthalmic treatments.

Proliferative diabetic retinopathy (PDR) is the most advanced and visually devastating stage of diabetic eye disease. It arises from retinal ischaemia-driven neovascularisation in patients with longstanding or poorly-controlled diabetes mellitus.1 In October 2025, ranibizumab (Lucentis) received Pharmaceutical Benefits Scheme (PBS) listing for the treatment for PDR, making it the first government-subsidised intravitreal anti-vascular endothelial growth factor (anti-VEGF) ther

Age-related macular degeneration (AMD), already one of the leading causes of blindness and vision impairment in the Western world,1,2 is expected to impact 1.7 million Australians by 2030.3 Approximately 10.5% of Australians over the age of 50 have intermediate AMD, and the Beckman Classification system predicts that a person with intermediate AMD in one or other eye can have up to a 47.3% five-year risk of progressing to late AMD, characterised by geographic atrophy (GA) or

We all have everyday habits, from the simple to the complex; from those that serve us well to those that may be detrimental. How can these everyday habits be formed, changed or used to medical advantage? This article explores technology developments and communication opportunities that can help improve patient compliance when it comes to contact lens wear.

In ophthalmology, small errors can have big consequences. A short consultation involves visual acuity measurements, intraocular pressure readings, imaging interpretations, medication adjustments, and surgical planning. As Aayushi Khillan writes, capturing this accurately isn’t optional; it underpins patient safety and continuity of care.

As patient expectations continue to evolve alongside increasingly digital lifestyles, advances in intraocular lens technology are reshaping the conversation around cataract surgery. mivision spoke with Associate Professor Chandra Bala, from personalEYES, about his experience with the Clareon PanOptix Pro intraocular lens (IOL) – Alcon’s next generation full visual range IOL.

Patients are increasingly educated – and demanding – when it comes to visual outcomes post cataract/lens exchange surgery. And, the intraocular lens (IOL) options for meeting their expectations are continually expanding. So how do you go about explaining the nuances that come with every suitable IOL? Indeed, how do you as an eye care professional, fully comprehend these nuances yourself?

As rates of diabetes continue to rise globally, the early detection and management of diabetic eye disease has become an increasingly important focus for eye care professionals. Retinal imaging technologies, such as Optos ultra-widefield (UWF) imaging, are changing the way clinicians document and assess the retina, particularly by capturing up to 200° of the retina in a single image.

Navigating Your Options for Home & Practice

Securing the Right Premises Lease

Optometry’s future health-system role will be defined by whether relevant information reaches the right person, in the right format, for the right clinical action, writes Peter Larsen.

There is a clear sense of momentum building within Tasmania’s optometry sector, with continued collaboration and engagement placing the state in a strong position to deliver better outcomes for its communities.

In 2025, EssilorLuxottica began rolling out audiology services across its network of optometry practices. Initially offering hearing tests and hearing aids, the launch of Nuance Audio – eyewear that integrates directional hearing support – has broadened the company’s portfolio beyond vision correction into integrated hearing solutions. EssilorLuxottica now offers complete optical and audiology services. mivision spoke to Naomi Nicolinas, Director of Audiology Services for Ess

Optometrists turned up in droves for the highly anticipated Super Sunday conference in Sydney that, every year, delivers an inspiring mix of practical lectures on business, optometry, and ophthalmology. Doltone House, on the edge of Sydney Harbour in Pyrmont, was packed to capacity.

Summit 2026

40 Years of Engineering Excellence